Ara
Toplam kayıt 22, listelenen: 21-22
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
(Lippincott, Williams & Wilkins, 07.06.2022)
In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ...
The Relationship between Mortality and the Modified Nutrition Risk in Critically Ill (mNUTRIC) and Nutritional Risk Screening 2002 (NRS-2002) Scores in the Intensive Care Unit
(College of Physicians and Surgeons Pakistan, 2022)
Objective: To measure the effects on mortality of the Modified Nutrition Risk in Critically Ill (mNUTRIC) and Nutritional Risk Screening 2002 (NRS-2002) scores in critical patients in the Intensive Care Unit (ICU) and to ...